F. Française-de-psychiatrie, Conférence de consensus. Stratégies Thérapeutiques à long terme dans les psychoses schizophréniques, 1994.

M. Saoud and T. Amato, La Schizophrénie de l'adulte. Des causes aux traitements, 2006.

F. Française-de-psychiatrie, Conférence de consensus Schizophrénies débutantes :diagnostic et modalités thérapeutiques

O. Mondiale-de and L. Santé, CIM-10/ICD-10, Classification Internationale des Troubles Mentaux et des Troubles du Comportement. Descriptions Cliniques et Directives pour le Diagnostic, 1993.

A. Psychiatric-association and . Mini-dsm-iv-tr, Critères diagnostiques Traduction française par, 2000.

A. Jablenski, Epidemiology of Schizophrenia: A European Perspective, Schizophrenia Bulletin, vol.12, issue.1, pp.52-73, 1986.
DOI : 10.1093/schbul/12.1.52

J. Mcgrath, S. Saha, and J. Welham, A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology, BMC Medicine, vol.142, issue.Suppl, pp.1-22, 2004.
DOI : 10.1093/oxfordjournals.aje.a117645

S. A. Mednick, R. A. Machon, M. O. Huttunen, and D. Bonett, Adult Schizophrenia Following Prenatal Exposure to an Influenza Epidemic, Archives of General Psychiatry, vol.45, issue.2, pp.189-92, 1988.
DOI : 10.1001/archpsyc.1988.01800260109013

A. S. Brown, M. D. Begg, and S. Gravenstein, Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia, Archives of General Psychiatry, vol.61, issue.8, pp.774-80, 2004.
DOI : 10.1001/archpsyc.61.8.774

E. S. Susser and S. P. Lin, Schizophrenia After Prenatal Exposure to the Dutch Hunger Winter of 1944-1945, Archives of General Psychiatry, vol.49, issue.12, pp.983-991, 1992.
DOI : 10.1001/archpsyc.1992.01820120071010

E. Susser, R. Neugebauer, and H. W. Hoek, Schizophrenia After Prenatal Famine, Archives of General Psychiatry, vol.53, issue.1, pp.25-31, 1996.
DOI : 10.1001/archpsyc.1996.01830010027005

H. W. Hoek, A. S. Brown, and E. Susser, The Dutch Famine and schizophrenia spectrum disorders, Social Psychiatry and Psychiatric Epidemiology, vol.33, issue.8, pp.373-382, 1998.
DOI : 10.1007/s001270050068

R. G. Mccreadie, Conclusions, British Journal of Psychiatry, vol.170, issue.04, pp.334-341, 1997.
DOI : 10.1192/bjp.170.4.334

J. M. Hollister, P. Laing, and S. A. Mednick, Rhesus Incompatibility as a Risk Factor for Schizophrenia in Male Adults, Archives of General Psychiatry, vol.53, issue.1, pp.19-24, 1996.
DOI : 10.1001/archpsyc.1996.01830010021004

W. W. Eaton, P. B. Mortensen, and M. Frydenberg, Obstetric factors, urbanization and psychosis, Schizophrenia Research, vol.43, issue.2-3, pp.117-140, 2000.
DOI : 10.1016/S0920-9964(99)00152-8

A. Barbato, Schizophrenia and public health. WHO, Division of Mental Health and Prevention of Substance Abuse, 1996.

J. G. Gunderson, A. F. Frank, and H. M. Katz, Effects of Psychotherapy in Schizophrenia: II. Comparative Outcome of Two Forms of Treatment, Schizophrenia Bulletin, vol.10, issue.4, pp.564-98, 1984.
DOI : 10.1093/schbul/10.4.564

S. Pilling, P. Bebbington, and E. Kuipers, Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy, Psychological Medicine, vol.32, issue.05, pp.763-82, 2002.
DOI : 10.1017/S0033291702005895

S. Pilling, P. Bebbington, and E. Kuipers, Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation, Psychological Medicine, vol.32, issue.05, pp.783-91, 2002.
DOI : 10.1017/S0033291702005640

J. P. Mcevoy, P. L. Scheifler, and A. Frances, The Expert Consensus Guideline Series. Treatment of Schizophrenia 1999, J. Clin. Psychiatry, vol.60, issue.11, 1999.

. American-psychiatric-association, Pratice Guidelines for the Treatment of Patients with Schizophrenia. Part A: Treatment Recommandations for Patients with Schizophrenia, 2008.

J. Palazzolo, Observance médicamenteuse et psychiatrie, Paris, 2004.

R. Ice, Long-Term Compliance, Physical Therapy, vol.65, issue.12, pp.1832-1841, 1985.
DOI : 10.1093/ptj/65.12.1832

P. S. Applebaum and T. Crissot, Assessing Patients' Capacities to Consent to Treatment, New England Journal of Medicine, vol.319, issue.25, pp.1635-1643, 1988.
DOI : 10.1056/NEJM198812223192504

D. Zagury, Clinique, éthique et mutations sociales, Inform. Psychiatr, vol.74, issue.1, pp.47-56, 1998.

D. Larose, R??gion des Laurentides : Les habitudes de consommation de psychotropes chez les personnes ??g??es, Sant?? mentale au Qu??bec, vol.21, issue.1, pp.291-295, 1996.
DOI : 10.7202/032392ar

URL : http://www.erudit.org/fr/revues/smq/1996-v21-n1-smq1826/032392ar.pdf

J. Palazzolo and B. Lachaux, Entre compliance et liberté : le témoignage d'un patient, Encephale, vol.25, issue.6, pp.667-71, 1999.

P. J. Weiden and A. Zygmunt, Assessment of non-compliance in schizophrenia, J. Pract. Psy. Behav. Health, vol.3, issue.1, pp.106-116, 1997.

M. Reynaud and A. Malarewicz, La souffrance de l'homme. Luçon : Albin Michel, 1996.

J. A. Lieberman, Compliance issues in primary care, J. Clin. Psychiatry, vol.57, issue.7, pp.76-82, 1996.

J. Palazzolo and J. P. Chabannes, La compliance : du point de vue du patient, Inform. Psychiatr, vol.14, issue.10, pp.1017-1037, 1998.

J. L. Young, R. T. Spitz, M. Hillbrand, and G. Daneri, Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments and prospects, J. Am. Acad. Psychiatry Law, vol.27, issue.3, pp.426-470, 1999.

S. M. Ruscher, R. De-wit, and D. Mazmanian, Psychiatric patients' attitudes about medication and factors affecting non-compliance, Psychiatr. Serv, vol.48, pp.82-87, 1997.

W. S. Fenton, C. R. Blyler, and R. K. Heinssen, Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings, Schizophrenia Bulletin, vol.23, issue.4, pp.637-51, 1997.
DOI : 10.1093/schbul/23.4.637

B. J. Cuffel, J. Alford, and E. P. Fisher, Awareness of Illness in Schizophrenia and Outpatient Treatment Adherence, The Journal of Nervous and Mental Disease, vol.184, issue.11, pp.653-662, 1996.
DOI : 10.1097/00005053-199611000-00001

S. Teevan, Drug information on mindinfoline, Open Mind, vol.82, pp.6-7, 1995.

M. Birchwood, Early intervention in schizophrenia: Theoretical background and clinical strategies, British Journal of Clinical Psychology, vol.31, issue.3, pp.257-78, 1992.
DOI : 10.1111/j.2044-8260.1992.tb00994.x

B. Blaska, The Myriad Medication Mistakes in Psychiatry: A Consumer's View, Psychiatric Services, vol.41, issue.9, pp.993-1001, 1990.
DOI : 10.1176/ps.41.9.993

T. E. Hansen, D. E. Casey, and W. F. Hoffman, Neuroleptic Intolerance, Schizophrenia Bulletin, vol.23, issue.4, pp.567-82, 1997.
DOI : 10.1093/schbul/23.4.567

URL : https://academic.oup.com/schizophreniabulletin/article-pdf/23/4/567/5252374/23-4-567.pdf

W. W. Fleischhacker, S. D. Roth, and J. M. Kane, The Pharmacologic Treatment of Neuroleptic-Induced Akathisia, Journal of Clinical Psychopharmacology, vol.10, issue.1, pp.12-21, 1990.
DOI : 10.1097/00004714-199002000-00003

J. D. Wojcik, W. E. Falk, and J. S. Fink, A review of 32 cases of tardive dystonia, Am. J. Psychiatry, vol.148, pp.1055-1064, 1991.

D. Ginestet and V. Kapsambelis, Thérapeutique Médicamenteuse des Troubles Psychiatriques de l'Adulte. Paris : Flammarion, 1996.

S. K. Hoge, P. S. Appelbaum, T. Lawlor, J. C. Beck, R. Litman et al., A Prospective, Multicenter Study of Patients' Refusal of Antipsychotic Medication, Archives of General Psychiatry, vol.47, issue.10, pp.949-56, 1990.
DOI : 10.1001/archpsyc.1990.01810220065008

M. Atmaca, M. Kuloglu, E. Tezcan, and B. Ustundag, Serum Leptin and Triglyceride Levels in Patients on Treatment With Atypical Antipsychotics, The Journal of Clinical Psychiatry, vol.64, issue.5, pp.598-604, 2003.
DOI : 10.4088/JCP.v64n0516

S. Mukherjee, P. Decina, and V. Bocola, Diabetes mellitus in schizophrenic patients, Comprehensive Psychiatry, vol.37, issue.1, pp.68-73, 1996.
DOI : 10.1016/S0010-440X(96)90054-1

H. A. Nasrallah, A review of the effect of atypical antipsychotics on weight, Psychoneuroendocrinology, vol.28, pp.83-96, 2003.
DOI : 10.1016/S0306-4530(02)00114-2

M. D. Jibson and R. Tandon, New atypical antipsychotic medications, Journal of Psychiatric Research, vol.32, issue.3-4, pp.3-4215, 1998.
DOI : 10.1016/S0022-3956(98)00023-5

C. Vindreau, D. Ginestet, L. Colonna, M. Petit, and J. P. Lépine, Neuroleptiques à action prolongée, Dictionnaire des neuroleptiques, pp.243-248, 1989.

M. Girard, F. Granier, and J. P. Gardes, L'étude des concentrations des neuroleptiques à action prolongée dans le traitement des psychoses chroniques, Sem. Hop. Paris, vol.60, pp.929-962, 1985.

D. A. Johnson and N. F. Wright, Drug Prescribing for Schizophrenic Out-patients on Depot Injections, British Journal of Psychiatry, vol.156, issue.06, pp.827-861, 1990.
DOI : 10.1192/bjp.156.6.827

J. M. Kane, E. Aguglia, A. C. Altamura, A. Gutierrez, J. L. Brunello et al., Guidelines for depot antipsychotic treatment in schizophrenia, European Neuropsychopharmacology, vol.8, issue.1, pp.55-66, 1998.
DOI : 10.1016/S0924-977X(97)00045-X

P. Bouhours and J. C. Levron, Rispéridone : de la pharmacologie à la clinique, La lettre du pharmacologue, vol.11, issue.10, pp.32-44, 1997.

P. Chue, Risperidone long-acting injection, Expert Review of Neurotherapeutics, vol.32, issue.4, pp.435-481, 2003.
DOI : 10.1016/S0022-3956(97)00013-7

M. Eerdekens, I. Van-hove, B. Remmerie, and E. Mannaert, Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia, Schizophrenia Research, vol.70, issue.1, pp.91-100, 2004.
DOI : 10.1016/j.schres.2003.11.001

E. Mannaert, P. Bouhours, and J. C. Levron, Pharmacokinetic profile of long-acting injectable risperidone at steady-state : comparison with oral administration, L'Enc??phale, vol.31, issue.5, p.229, 2004.
DOI : 10.1016/S0013-7006(05)82420-0

P. Rédaction, Risperidone injectable LP:modifications du RCP minimes au regard des risques, Rev. Prescrire, vol.26, issue.278, p.815, 2006.

W. W. Fleischhacker, M. Eerdekens, K. Karcher, G. Remington, P. M. Llorca et al., Treatment of Schizophrenia With Long-Acting Injectable Risperidone, The Journal of Clinical Psychiatry, vol.64, issue.10, pp.1250-1257, 2003.
DOI : 10.4088/JCP.v64n1017

J. M. Kane, M. Eerdekens, J. P. Lindenmayer, S. J. Keith, M. Lesem et al., Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic, American Journal of Psychiatry, vol.160, issue.6, pp.1125-1132, 2003.
DOI : 10.1176/appi.ajp.160.6.1125

Y. Bloch, S. Mendlovic, S. Strupinsky, A. Altshuler, S. Fennig et al., Injections of Depot Antipsychotic Medications in Patients Suffering From Schizophrenia, The Journal of Clinical Psychiatry, vol.62, issue.11, pp.855-864, 2001.
DOI : 10.4088/JCP.v62n1104

J. M. Kane, S. Leucht, and D. Carpenter, The Expert Consensus Guideline Series. Optimizing pharmacologic treatment of psychotic disorders. Introduction : methods, commentary, and summary, J Clin Psychiatry, vol.64, issue.12, pp.5-19, 2003.

S. Harrison, T. Goa, and K. L. , Long-Acting Risperidone, CNS Drugs, vol.12, issue.5, pp.113-132, 2004.
DOI : 10.2165/00023210-200418020-00005

S. Tribolet, Vocabulaire de santé mentale. Paris : Editions de santé, 2006.